These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 15865813)

  • 1. Polycystic ovary syndrome.
    Al-Inany H
    Clin Evid; 2004 Dec; (12):2678-88. PubMed ID: 15865813
    [No Abstract]   [Full Text] [Related]  

  • 2. Polycystic ovary syndrome.
    Al-Inany H
    Clin Evid; 2005 Dec; (14):2343-51. PubMed ID: 16620491
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of the clinical efficacy of flutamide and spironolactone plus ethinyloestradiol/cyproterone acetate in the treatment of hirsutism: a randomised controlled study.
    Karakurt F; Sahin I; Güler S; Demirbas B; Culha C; Serter R; Aral Y; Bavbek N
    Adv Ther; 2008 Apr; 25(4):321-8. PubMed ID: 18389188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interventions for hirsutism (excluding laser and photoepilation therapy alone).
    van Zuuren EJ; Fedorowicz Z; Carter B; Pandis N
    Cochrane Database Syst Rev; 2015 Apr; 2015(4):CD010334. PubMed ID: 25918921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hirsutism - from diagnosis to use of antiandrogens.
    Unluhizarci K; Karaca Z; Kelestimur F
    Front Horm Res; 2013; 40():103-14. PubMed ID: 24002408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyproterone acetate/ethinyl estradiol for acne and hirsutism: time to revise prescribing policy.
    Franks S; Layton A; Glasier A
    Hum Reprod; 2008 Feb; 23(2):231-2. PubMed ID: 18083746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The treatment of polycystic ovary syndrome.
    Ajossa S; Guerriero S; Paoletti AM; Orrù M; Melis GB
    Minerva Ginecol; 2004 Feb; 56(1):15-26. PubMed ID: 14973407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combined use of metformin and Diane35 in polycystic ovary syndrome].
    Mitkov M; Pekhlivanov B; Terzieva D
    Akush Ginekol (Sofiia); 2004; 43(3):34-7. PubMed ID: 15341255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiandrogen treatment of polycystic ovary syndrome.
    Rittmaster RS
    Endocrinol Metab Clin North Am; 1999 Jun; 28(2):409-21. PubMed ID: 10352926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of hirsutism in HAIR-AN syndrome using flutamide, spironolactone, and birth control therapy.
    Zemtsov A; Wilson L
    Arch Dermatol; 1997 Apr; 133(4):431-3. PubMed ID: 9126004
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapeutic alternatives for the hirsute woman.
    Bassaw B; Maharaj R; Ali A; Roopnarinesingh S
    West Indian Med J; 1992 Mar; 41(1):12-4. PubMed ID: 1533080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Finasteride versus cyproterone acetate-estrogen regimens in the treatment of hirsutism.
    Beigi A; Sobhi A; Zarrinkoub F
    Int J Gynaecol Obstet; 2004 Oct; 87(1):29-33. PubMed ID: 15464773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study to illustrate the benefits of using ethinyl estradiol-cyproterone acetate over metformin in patients with polycystic ovarian syndrome.
    Mhao NS; Al-Hilli AS; Hadi NR; Jamil DA; Al-Aubaidy HA
    Diabetes Metab Syndr; 2016; 10(1 Suppl 1):S95-8. PubMed ID: 26703220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antiandrogen therapy in the polycystic ovary syndrome].
    Messina M; Milani P; Gentile L; Gellona A; Monaco A; Manieri C
    Minerva Endocrinol; 1987; 12(3):231-8. PubMed ID: 3657744
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of an oral contraceptive containing cyproterone acetate (Diane-35) on the symptoms, hormone profile, and ovarian volume of hirsute women with polycystic ovarian syndrome.
    Prelević GM; Puzigaća Z; Balint-Perić LA
    Ann N Y Acad Sci; 1993 May; 687():255-62. PubMed ID: 8323181
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of desogestrel/ethinyl estradiol plus spironolactone versus cyproterone acetate/ethinyl estradiol in the treatment of polycystic ovary syndrome: a randomized controlled trial.
    Leelaphiwat S; Jongwutiwes T; Lertvikool S; Tabcharoen C; Sukprasert M; Rattanasiri S; Weerakiet S
    J Obstet Gynaecol Res; 2015 Mar; 41(3):402-10. PubMed ID: 25319761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spironolactone as a single agent for long-term therapy of hirsute patients.
    Spritzer PM; Lisboa KO; Mattiello S; Lhullier F
    Clin Endocrinol (Oxf); 2000 May; 52(5):587-94. PubMed ID: 10792338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism.
    Tartagni M; Schonauer LM; De Salvia MA; Cicinelli E; De Pergola G; D'Addario V
    Fertil Steril; 2000 Apr; 73(4):718-23. PubMed ID: 10731531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic review of commonly used medical treatments for hirsutism in women.
    Koulouri O; Conway GS
    Clin Endocrinol (Oxf); 2008 May; 68(5):800-5. PubMed ID: 17980017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Finasteride and flutamide in the treatment of hirsutism].
    Falsetti L; De Fusco D; Rosina B
    Minerva Ginecol; 1997 Oct; 49(10):463-8. PubMed ID: 9463180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.